American Journal of Obstetrics & Gynecology
Volume 202, Issue 6 , Pages 555.e1-555.e10 , June 2010

Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor

Presented in abstract form at the 28th Annual Meeting of the Society for Maternal-Fetal Medicine, Dallas, TX, Jan. 28-Feb. 2, 2008.

  • Leonardo Pereira, MD, MCR

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR
    • Corresponding Author InformationReprints: Leonardo Pereira, MD, Division of Maternal Fetal Medicine, 3181 SW Sam Jackson Park Rd., Mailcode L458, Oregon Health & Science University, Portland, OR 97239
    • ,
  • Ashok P. Reddy, PhD

      Affiliations

    • Diabetomics, LLC, Portland, OR
    • ,
  • Amanda L. Alexander, BS

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR
    • ,
  • Xinfang Lu, MS

      Affiliations

    • Proteogenix, Inc, Beaverton, OR
    • ,
  • Jodi A. Lapidus, PhD

      Affiliations

    • Division of Biostatistics, Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR
    • Proteogenix, Inc, Beaverton, OR
    • ,
  • Michael G. Gravett, MD

      Affiliations

    • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA
    • ,
  • Srinivasa R. Nagalla, MD

      Affiliations

    • Diabetomics, LLC, Portland, OR

Received 2 July 2009 ,Revised 24 December 2009 ,Accepted 17 February 2010.

References 

  1. Martin J, Hamilton B, Sutton P, Ventura S, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep. 2006;55:1–101
  2. Copper RL, Goldenberg RL, Creasy RK, et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol. 1993;169:352–366
  3. Meis PJ, Klebanoff M, Thom E, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–2385
  4. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188:419–424
  5. Simmer K, Lort-Phillips L, James C, Thompson RPH. A double-blind trial of zinc supplementation in pregnancy. Eur J Clin Nutr. 1991;45:139–144
  6. To MS, Skentou CA, Royston P, Yu CK, Nicolaides KH. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol. 2006;27:362–367
  7. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005;106:181–189
  8. Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360:1489–1497
  9. Morken NH, Vogel I, Kallen K, et al. Reference population for international comparisons and time trend surveillance of preterm delivery proportions in three countries. BMC Women's Health. 2008;8:16
  10. Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a huge review. Genet Med. 2005;7:593–604
  11. Sagiv SK, Mendola P, Loomis D, et al. A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001. Environ Health Perspect. 2005;113:602–606
  12. Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand. 2005;84:516–525
  13. Iams JD, Goldenberg RL, Mercer BM, et al. The Preterm Prediction study: recurrence risk of spontaneous preterm birth. Am J Obstet Gynecol. 1998;178:35–40
  14. Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260–267
  15. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl L Med. 1992;327:308–312
  16. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol. 1992;163:767–772
  17. Buhimschi CS, Weiner CP, Buhimschi IA. Clinical proteomics: a novel diagnostic tool for the new biology of preterm labor: part I, proteomics tools. Obstet Gynecol Surv. 2006;61:481–486
  18. Pereira L, Reddy AP, Jacob T, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res. 2007;6:1269–1276
  19. Nagalla SR, Canick JA, Jacob T, et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J Proteome Res. 2007;6;:1245–1257
  20. Gravett MG, Thomas A, Schneider KA, et al. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res. 2007;6:89–96
  21. Gravett MG, Novy MJ, Rosenfeld RG, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004;292:462–469
  22. Old WM, Meyer-Arendt K, Aveline-Wolf L, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics. 2005;4:1487–1502
  23. Zybailov B, Coleman MK, Florens L, Washburn MP. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem. 2005;77:6218–6224
  24. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res. 2006;5:2339–2347
  25. Moawad AH, Goldenberg RL, Mercer B, et al. The Preterm Prediction study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol. 2002;186:990–996
  26. Menon R, Fortunato SJ, Thorsen P, Williams S. Genetic associations in preterm birth: a primer of marker selection, study design, and data analysis. J Soc Gynecol Investig. 2006;13:531–541
  27. Astolfi P, De Pasquale A, Zonta L. Late childbearing and its impact on adverse pregnancy outcome: stillbirth, preterm delivery and low birth weight. Rev Epidemiol Sante Publique. 2005;53(suppl 2):2S97-105
  28. Heine RP, McGregor JA, Goodwin TM, et al. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol. 2000;96:490–497
  29. Revah A, Hannah ME, Sue-A-Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol. 1998;15:613–621
  30. Surbek D, Bosiger H, Pavic N, Huber P, Almendral AC, Holzgreve W. [Fetal fibronectin as a marker of prematurity in a high risk patient sample]. Z Geburtshilfe Neonatol. 1997;201:15–20
  31. Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996;334:567–572
  32. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol. 2001;15(suppl):78–89
  33. Wang X, Zuckerman B, Kaufman G, et al. Molecular epidemiology of preterm delivery: methodology and challenges. Paediatr Perinat Epidemiol. 2001;15(suppl):63–77
  34. Roman AS, Rebarber A, Pereira L, Sfakianaki AK, Mulholland J, Berghella V. The efficacy of sonographically indicated cerclage in multiple gestations. J Ultrasound Med. 2005;24:763–768
  35. Rouse DJ, Caritis SN, Peaceman AM, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: a trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007;357:454–461
  36. Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997;90:230–234
  37. Romero R, Sibai BM, Sanchez-Ramos L, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 2000;182:1173–1183
  38. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339:313–320
  39. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med. 2007;357:477–487

 Supported by the Oregon Clinical and Translational Research Institute, Grant no. UL1 RR024140 from the National Center for Research Resources, a component of the National Institutes of Health, and National Institutes of Health Roadmap for Medical Research.

 ProteoGenix, Inc, provided the laboratory and equipment that made this research possible. Oregon Health & Science University and Drs Gravett, Nagalla, and Lapidus have a significant financial interest in ProteoGenix, Inc, a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and a management plan has been approved by the Oregon Health & Science University Integrity Program Oversight Council and by the University of Washington Office of Technology Transfer.

 Cite this article as: Pereira L, Reddy AP, Alexander AL, et al. Insights into the multifactorial nature of preterm birth: proteomic profiling of the maternal serum glycoproteome and maternal serum peptidome among women in preterm labor. Am J Obstet Gynecol 2010;202:555.e1-10.

PII: S0002-9378(10)00274-7

doi: 10.1016/j.ajog.2010.02.048

American Journal of Obstetrics & Gynecology
Volume 202, Issue 6 , Pages 555.e1-555.e10 , June 2010

Article Tools

* Image Usage & Resolution